Physician Wealth Advisors’s Sionna Therapeutics SION Stock Holding History

Physician Wealth Advisors’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$369	Buy	+70	New	+$1.61K	﹤0.01%	2368

Other funds holding SION

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Physician Wealth Advisors's SION Position: Q3 2026 in Review

Physician Wealth Advisors opened a new position in Sionna Therapeutics (SION) in Q3 2026: 70 shares worth $369. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings.

20 funds tracked by Wall St. Rank hold SION as of Q3 2026.

Physician Wealth Advisors held 70 shares of Sionna Therapeutics worth $369 as of Q3 2026.
Sionna Therapeutics was a new Physician Wealth Advisors position in Q3 2026.
Sionna Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2368 holding.
20 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.